Search
for
Sort by
Research 151–180 of 1000+
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- COVID-19 and Sex Differences
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Dermatologic manifestations of endocrine disorders
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Idiopathic Hirsutism*
- Side effects of common acne treatments
- Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options
- Gender-Affirming Hormone Therapy for Transgender Females
- Diagnostic approach to low‐renin hypertension
- Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre
- Hair growth-modulation by adrenergic drugs
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Cutaneous drug reactions
- PROTECTIVE EFFECT OF TRIBULUS TERRESTRIS ON HEPATO-BIOCHEMICAL PARAMETERS OF ALBINO RAT AFTER TREATMENT WITH DRUG CYPROTERONE ACETATE
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- Drugs that affect autonomic functions or the extrapyramidal system
- Health Messages
- Questions and answers for clinical insights
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness-Difference between Clinical Trials and Private Office Follow-Up: Influences on Prescribing Habits Evaluated